India Movers: BHEL, Cyient, Dr. Reddy's, GOCL, Maruti Suzuki, NHPC, REC

  • Arun Goswami
  • India Mumbai
  • Mar 28, 2024
  • The NHPC board approved the sale of medium-term debt securities to raise capital. The REC board increased the company's borrowing plans. GOCL plans to develop a large tract of land in Hyderabad. 

    Benchmark indexes in Mumbai advanced, and extended holiday-shortened weekly gains to more than 1.4%. 

    The Sensex index increased 0.5% to 73,360.05, and the Nifty index edged up 0.5% to 22,225.40. 

    On the Mumbai stock exchange, 47 stocks traded at their 52-week highs and 56 stocks traded at their 52-week lows.

    Maruti Suzuki India decreased 1% to ₹12,391.10, and the largest automaker in India reshuffled its management ranks in several business functions and activities. 

    Bharat Heavy Electricals jumped 2% to ₹248.10 after Adani Power awarded the company an an order to build a ₹4,000 crore power plant project in Chhattisgarh.  

    Dr. Reddy's Labs added 1.4% to ₹6,128.10, and the company struck a nationwide distribution partnership with Sanofi India for its vaccine products. 

    NHPC jumped 1.2% to ₹90.0 after the company's board approved the company's plans to borrow 6,100 crore in the fiscal year 2025.

    Moreover, the board also approved the company's plans to close the Loktak Downstream Hydroelectric Project in west Manipur with an annual power capacity of 66 MW. 

    GOCL Corporation soared 10% to ₹417.85 after the company signed a preliminary agreement with Squarespace Infra City, based in Hyderabad, to monetize its 264.50-acre land facility in Kukatpally, Hyderabad. 

    REC Limited increased 1.9% to ₹453.95 after the company's board approved a borrowing limit of 1.6 lakh crore through the sale of short- and long-term debts and loans. 

    Cyient Ltd. added 1.7% to ₹1,976.65, and the company signed a collaboration with Deutsche Aircraft to design the  rear fuselage of a 40-seat turboprop aircraft. 

     

Annual Returns

Company Ticker 2025 2024 2023
Dr Reddy`s Laboratories Ltd RDY 1% -78% 28%